- How I treat smoldering myeloma (SMM)
- How I treat newly diagnosed multiple myeloma
- From risk stratification to risk-based therapy?
- Should we use MRD testing to determine therapy in multiple myeloma?
- Is CAR T cell therapy replacing autologous SCT?
- How I treat relapsed multiple myeloma
- Cell free DNA / circulating tumor cells to replace BM-biopsy and MRD measurement
- You can’t be immune for immune therapy anymore
- The future of multiple myeloma
- Other plasma cell dyscrasias
About the Conference:
ESH How to Diagnose and Treat meetings are disease-specific meetings that address state-of-the-art diagnostic and clinical management.
They are based on the presentation and analysis of real clinical cases. Voting technology is used as a self-evaluation tool and to increase scientific interaction.
The conference has been approved for 18 CME credit points by the European Board for Accreditation in Haematology (EBAH)
To meet the faculty, click here!
For more information, click here!
With the support of*:
Level 2 Conference Partner
*******
*ESH conference programmes are developed in strict scientific independence
with no input from corporate sponsors.